Inotuzumab Ozogamicin Injection

225 interactions 104 cited references

Also sold as: Besponsa Besponsa®

About Inotuzumab Ozogamicin Injection

Inotuzumab ozogamicin injection is used to treat certain acute lymphoblastic leukemia (ALL; a type of cancer that begins in the white blood cells) in adults who have not responded to previous cancer treatments. Inotuzumab ozogamicin injection is in a class of medications called monoclonal antibodies. It works by activa… Read the full Inotuzumab Ozogamicin Injection drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Pimozide Piperaquine Rubella Virus Vaccine, Live Saquinavir Smallpox Monkeypox Vaccine Sparfloxacin

21 Contraindicated 204 Major

All (225) Contraindicated (21) Major (204)

Major

Inotuzumab Ozogamicin Injection Felbamate Felbatol Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Fexinidazole An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Fingolimod Gilenya Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Flecainide Tambocor® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Fluconazole Diflucan Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Fluoxetine RECONCILE Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Formoterol Perforomist Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Foscarnet Foscavir Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Fosfomycin Contepo An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Fosphenytoin Cerebyx Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Fostemsavir Rukobia Increased risk of torsade de pointes Details Inotuzumab Ozogamicin Injection Galantamine Razadyne Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Gatifloxacin Zymaxid Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Gemifloxacin Factive Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Gepirone Exxua An increased risk of QT interval prolongation and cardiac arrhythmias Details Inotuzumab Ozogamicin Injection Gepotidacin Blujepa An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Givinostat Duvyzat Increased risk of QT interval prolongation and torsade de pointes Details Inotuzumab Ozogamicin Injection Glasdegib Daurismo Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Gonadorelin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Goserelin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Granisetron Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Halofantrine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Haloperidol Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Histrelin Supprelin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Hydroquinidine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Hydroxyzine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ibutilide Corvert Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Iloperidone Fanapt Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Imipramine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Influenza Virus Vaccine, Live An increased risk of infection by the live vaccine Details Inotuzumab Ozogamicin Injection Isoflurane Fluriso An increased risk of QT interval prolongation and torsade de pointes Details Inotuzumab Ozogamicin Injection Itraconazole Sporanox Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ivabradine Corlanor Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ivosidenib Tibsovo An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ketoconazole Extina Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Lapatinib Tykerb Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Lefamulin Xenleta Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Inotuzumab Ozogamicin Injection Leuprolide Eligard Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.